by In2Pharma | Feb 27, 2026 | News
‘Adaptogen’ and ‘lozenges’ The Netherlands The Keuringsraad published an update concerning food supplements and the use of specific terms in product labelling and advertising. The clarification addresses the terminology “adaptogen” (“adaptogeen”) and “lozenges”...
by In2Pharma | Feb 27, 2026 | News
The Netherlands The Keuringsraad has announced a change in how toothpastes carrying a CE mark are treated under self-care advertising rules. The Keuringsraad reviews consumer advertising for, among other things, self‑care medical devices against the CPMH (Code...
by In2Pharma | Feb 13, 2026 | News
Belgium The FAMHP will launch a new platform for managing GDP inspections which will replace the current method. An introduction session will be organized by the FAMHP to present the new platform. The platform will be used, among other things, to send inspection...
by In2Pharma | Jan 20, 2026 | News
Belgium The FAMHP has updated the web portal ‘Co-responsibility’ on 14 January 2026. The main goal of this update is to enhance safety, harmonize GMP and GDP processes, and improve the traceability of inspection document archiving. The most important changes are: The...
by In2Pharma | Jan 7, 2026 | News
Belgium As from 11 December 2025, a new Royal Decree (RD) has entered into force that substantially amends the rules concerning parallel distribution and parallel import of medicinal products for human use in Belgium. This Decree replaces the Royal Decree of 19 April...
